“Cure Rates for Tuberculous Cervical Lymphadenopathy after 6-month or 9-month Anti-tuberculous Therapy”, Acta Med Philipp, vol. 58, no. 16, Sep. 2024, doi: 10.47895/amp.v58i16.4900.